(DKS) Dick’s Sporting Goods - Ratings and Ratios
Sporting Goods, Apparel, Footwear, Fitness Equipment, Outdoor Gear
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 39.4% |
| Value at Risk 5%th | 55.6% |
| Relative Tail Risk | -14.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.21 |
| Alpha | -12.53 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.380 |
| Beta | 1.446 |
| Beta Downside | 1.249 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.73% |
| Mean DD | 10.56% |
| Median DD | 9.22% |
Description: DKS Dick’s Sporting Goods October 16, 2025
DICK Sports Goods, Inc. (NYSE: DKS) is a U.S.-based omni-channel retailer that sells a broad assortment of sporting-goods hardlines, apparel, footwear and accessories through its flagship stores, specialty concepts (e.g., Golf Galaxy, Moosejaw, Public Lands, Going Going Gone!), and digital channels, including a youth-sports mobile app called GameChanger.
In FY 2023 the company generated roughly $10.5 billion in revenue, with e-commerce sales accelerating ~12% year-over-year and same-store sales modestly positive (+2%) despite a soft discretionary environment. Key economic drivers include consumer confidence in discretionary spending, inflation-adjusted pricing pressure, and labor-cost trends that have compressed operating margins. The broader specialty-retail sector remains sensitive to macro-backdrop shifts, but DKS’s diversified brand portfolio and “House of Sport” experiential format help mitigate foot-traffic volatility.
For a deeper, data-driven look at DKS’s valuation assumptions and scenario outcomes, the ValueRay platform offers a concise analytical dashboard worth exploring.
DKS Stock Overview
| Market Cap in USD | 18,567m |
| Sub-Industry | Other Specialty Retail |
| IPO / Inception | 2002-10-16 |
| Return 12m vs S&P 500 | -4.57% |
| Analyst Rating | 3.65 of 5 |
DKS Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.34% |
| Yield on Cost 5y | 9.37% |
| Yield CAGR 5y | 36.92% |
| Payout Consistency | 90.8% |
| Payout Ratio | 33.6% |
DKS Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 21.64% |
| CAGR/Max DD Calmar Ratio | 0.66 |
| CAGR/Mean DD Pain Ratio | 2.05 |
| Current Volume | 1143.8k |
| Average Volume | 932.1k |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (1.17b TTM) > 0 and > 6% of Revenue (6% = 826.3m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -3.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.06% (prev 16.85%; Δ -1.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 1.42b > Net Income 1.17b (YES >=105%, WARN >=100%) |
| Net Debt (3.38b) to EBITDA (2.02b) ratio: 1.67 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (81.0m) change vs 12m ago -2.14% (target <= -2.0% for YES) |
| Gross Margin 36.10% (prev 35.54%; Δ 0.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 133.5% (prev 135.0%; Δ -1.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 29.80 (EBITDA TTM 2.02b / Interest Expense TTM 53.9m) >= 6 (WARN >= 3) |
Altman Z'' 5.39
| (A) 0.19 = (Total Current Assets 5.05b - Total Current Liabilities 2.98b) / Total Assets 10.69b |
| (B) 0.64 = Retained Earnings (Balance) 6.84b / Total Assets 10.69b |
| (C) 0.16 = EBIT TTM 1.61b / Avg Total Assets 10.31b |
| (D) 0.93 = Book Value of Equity 6.84b / Total Liabilities 7.34b |
| Total Rating: 5.39 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.27
| 1. Piotroski 8.0pt |
| 2. FCF Yield 2.12% |
| 3. FCF Margin 3.37% |
| 4. Debt/Equity 1.37 |
| 5. Debt/Ebitda 1.67 |
| 6. ROIC - WACC (= 16.69)% |
| 7. RoE 37.05% |
| 8. Rev. Trend 37.83% |
| 9. EPS Trend -34.73% |
What is the price of DKS shares?
Over the past week, the price has changed by -7.95%, over one month by -10.27%, over three months by -8.62% and over the past year by +6.74%.
Is DKS a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 15
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the DKS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 241.8 | 19.4% |
| Analysts Target Price | 241.8 | 19.4% |
| ValueRay Target Price | 241 | 18.9% |
DKS Fundamental Data Overview November 21, 2025
P/E Trailing = 14.448
P/E Forward = 13.8504
P/S = 1.3481
P/B = 5.6178
P/EG = 2.6441
Beta = 1.191
Revenue TTM = 13.77b USD
EBIT TTM = 1.61b USD
EBITDA TTM = 2.02b USD
Long Term Debt = 1.48b USD (from longTermDebt, last quarter)
Short Term Debt = 505.0m USD (from shortTermDebt, last quarter)
Debt = 4.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.38b USD (from netDebt column, last quarter)
Enterprise Value = 21.94b USD (18.57b + Debt 4.61b - CCE 1.23b)
Interest Coverage Ratio = 29.80 (Ebit TTM 1.61b / Interest Expense TTM 53.9m)
FCF Yield = 2.12% (FCF TTM 464.8m / Enterprise Value 21.94b)
FCF Margin = 3.37% (FCF TTM 464.8m / Revenue TTM 13.77b)
Net Margin = 8.52% (Net Income TTM 1.17b / Revenue TTM 13.77b)
Gross Margin = 36.10% ((Revenue TTM 13.77b - Cost of Revenue TTM 8.80b) / Revenue TTM)
Gross Margin QoQ = 37.06% (prev 36.70%)
Tobins Q-Ratio = 2.05 (Enterprise Value 21.94b / Total Assets 10.69b)
Interest Expense / Debt = 0.35% (Interest Expense 16.1m / Debt 4.61b)
Taxrate = 25.19% (128.4m / 509.8m)
NOPAT = 1.20b (EBIT 1.61b * (1 - 25.19%))
Current Ratio = 1.70 (Total Current Assets 5.05b / Total Current Liabilities 2.98b)
Debt / Equity = 1.37 (Debt 4.61b / totalStockholderEquity, last quarter 3.36b)
Debt / EBITDA = 1.67 (Net Debt 3.38b / EBITDA 2.02b)
Debt / FCF = 7.27 (Net Debt 3.38b / FCF TTM 464.8m)
Total Stockholder Equity = 3.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.98% (Net Income 1.17b / Total Assets 10.69b)
RoE = 37.05% (Net Income TTM 1.17b / Total Stockholder Equity 3.17b)
RoCE = 34.52% (EBIT 1.61b / Capital Employed (Equity 3.17b + L.T.Debt 1.48b))
RoIC = 25.83% (NOPAT 1.20b / Invested Capital 4.65b)
WACC = 9.14% (E(18.57b)/V(23.18b) * Re(11.34%) + D(4.61b)/V(23.18b) * Rd(0.35%) * (1-Tc(0.25)))
Discount Rate = 11.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.95%
[DCF Debug] Terminal Value 59.35% ; FCFE base≈578.5m ; Y1≈411.4m ; Y5≈220.8m
Fair Price DCF = 40.61 (DCF Value 2.68b / Shares Outstanding 66.1m; 5y FCF grow -33.96% → 3.0% )
EPS Correlation: -34.73 | EPS CAGR: -56.37% | SUE: -4.0 | # QB: 0
Revenue Correlation: 37.83 | Revenue CAGR: 7.90% | SUE: 0.82 | # QB: 0
Additional Sources for DKS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle